These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32122431)

  • 1. Preventing Covert Brain Infarct-Related Cognitive Impairment and Dementia.
    Durrani R; Hill MD; Smith EE
    Can J Neurol Sci; 2020 Jul; 47(4):456-463. PubMed ID: 32122431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI Substudy.
    Sharma M; Hart RG; Smith EE; Bosch J; Eikelboom JW; Connolly SJ; Dyal L; Reeh KW; Casanova A; Diaz R; Lopez-Jaramillo P; Ertl G; Störk S; Dagenais GR; Lonn EM; Ryden L; Tonkin AM; Varigos JD; Bhatt DL; Branch KRH; Probstfield JL; Kim JH; O'Donnell M; Vinereanu D; A A Fox K; Liang Y; Liu L; Zhu J; Pogosova N; Maggioni AP; Avezum A; Piegas LS; Keltai K; Keltai M; Berkowitz SD; Yusuf S
    Stroke; 2020 Oct; 51(10):2901-2909. PubMed ID: 32951537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular cognitive impairment.
    Farooq MU; Gorelick PB
    Curr Atheroscler Rep; 2013 Jun; 15(6):330. PubMed ID: 23612956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of Covert Brain Infarct Subtype and Risk of Death and Vascular Events.
    Gutierrez J; Gil-Guevara A; Ramaswamy S; DeRosa J; Di Tullio MR; Cheung K; Rundek T; Sacco RL; Wright CB; Elkind MSV
    Stroke; 2020 Jan; 51(1):90-98. PubMed ID: 31766980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-stroke memory impairment among patients with vascular mild cognitive impairment.
    Cho SJ; Yu KH; Oh MS; Jung S; Lee JH; Koh IS; Bae HJ; Kang Y; Lee BC;
    BMC Neurol; 2014 Dec; 14():244. PubMed ID: 25927318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dementia and hypertension].
    Lüders S; Schrader J
    Dtsch Med Wochenschr; 2015 Oct; 140(21):1599-603. PubMed ID: 26488099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive consequences of multiple lacunes and leukoaraiosis as vascular cognitive impairment in community-dwelling elderly individuals.
    Koga H; Takashima Y; Murakawa R; Uchino A; Yuzuriha T; Yao H
    J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):32-7. PubMed ID: 19110142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of cognitive impairment: scientific guidance and windows of opportunity.
    Gorelick PB
    J Neurochem; 2018 Mar; 144(5):609-616. PubMed ID: 28677324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular cognitive impairment: epidemiology, subtypes, diagnosis and management.
    Black SE
    J R Coll Physicians Edinb; 2011 Mar; 41(1):49-56. PubMed ID: 21365068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of silent brain infarcts associated with cognitive deficits in an economically disadvantaged population.
    Squarzoni P; Tamashiro-Duran JH; Duran FLS; Leite CC; Wajngarten M; Scazufca M; Menezes PR; Lotufo PA; Alves TCTF; Busatto GF
    Clinics (Sao Paulo); 2017 Aug; 72(8):474-480. PubMed ID: 28954006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical presentations and epidemiology of vascular dementia.
    Smith EE
    Clin Sci (Lond); 2017 Jun; 131(11):1059-1068. PubMed ID: 28515342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerotic risk factors, vascular cognitive impairment, and Alzheimer disease.
    Kovacic JC; Fuster V
    Mt Sinai J Med; 2012; 79(6):664-73. PubMed ID: 23239205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol prevents cognitive deficits by attenuating oxidative damage and inflammation in rat model of streptozotocin diabetes induced vascular dementia.
    Gocmez SS; Şahin TD; Yazir Y; Duruksu G; Eraldemir FC; Polat S; Utkan T
    Physiol Behav; 2019 Mar; 201():198-207. PubMed ID: 30550811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular cognitive impairment in diabetes mellitus: are prevention and treatment effective?
    Zavoreo I; Madžar Z; Demarin V; Kes VB
    Acta Clin Croat; 2014 Sep; 53(3):326-33. PubMed ID: 25509243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ratio of apoB/LDL: a potential clinical index for vascular cognitive impairment.
    Qian C; Tan F
    BMC Neurol; 2016 Nov; 16(1):243. PubMed ID: 27887584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of vascular cognitive impairment and dementia.
    Erkinjuntti T
    J Neural Transm Suppl; 2002; (63):91-109. PubMed ID: 12597611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stratifying Future Stroke Risk with Incidentally Discovered White Matter Disease Severity and Covert Brain Infarct Site.
    Wang AY; Leung LY; Puttock EJ; Luetmer PH; Kallmes DF; Nelson J; Fu S; Zheng C; Liu H; Chen W; Kent DM
    Cerebrovasc Dis; 2023; 52(1):117-122. PubMed ID: 35760063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular risk factors and cognitive disorders.
    Debette S
    Rev Neurol (Paris); 2013 Oct; 169(10):757-64. PubMed ID: 24035574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trials and Treatments for Vascular Brain Health: Risk Factor Modification and Cognitive Outcomes.
    Kivipelto M; Palmer K; Hoang TD; Yaffe K
    Stroke; 2022 Feb; 53(2):444-456. PubMed ID: 35000424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive Impairment and Dementia After Stroke: Design and Rationale for the DISCOVERY Study.
    Rost NS; Meschia JF; Gottesman R; Wruck L; Helmer K; Greenberg SM;
    Stroke; 2021 Aug; 52(8):e499-e516. PubMed ID: 34039035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.